Guardant Suits Against Tempus AI Clear Dismissal Bids
A Delaware federal judge has refused to throw out litigation accusing Tempus AI Inc. of infringing Guardant Health Inc. patents covering technology used to analyze cancer-related genetic data and help guide...To view the full article, register now.
Already a subscriber? Click here to view full article